A2A Pharmaceuticals, Inc. 4/A
4/A · Biomea Fusion, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4/AAmended
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-03-31$31.25/sh−200,000$6,250,000→ 4,100,000 total
Footnotes (1)
- [F1]A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64. Additional details of the individual transactions are available upon request.